Repligen Stock Buy Hold or Sell Recommendation
| RGEN Stock | USD 150.62 8.18 5.74% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Repligen is 'Hold'. The recommendation algorithm takes into account all of Repligen's available fundamental, technical, and predictive indicators you will find on this site.
Check out Repligen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide. In addition, we conduct extensive research on individual companies such as Repligen and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Repligen |
Execute Repligen Buy or Sell Advice
The Repligen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Repligen. Macroaxis does not own or have any residual interests in Repligen or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Repligen's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Repligen Trading Alerts and Improvement Suggestions
| Repligen generated a negative expected return over the last 90 days | |
| Repligen has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 634.44 M. Net Loss for the year was (25.51 M) with profit before overhead, payroll, taxes, and interest of 319.5 M. | |
| Over 95.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Parnassus Investments LLC Sells 15,2 Shares of Repligen Co. |
Repligen Returns Distribution Density
The distribution of Repligen's historical returns is an attempt to chart the uncertainty of Repligen's future price movements. The chart of the probability distribution of Repligen daily returns describes the distribution of returns around its average expected value. We use Repligen price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Repligen returns is essential to provide solid investment advice for Repligen.
| Mean Return | 0.06 | Value At Risk | -3.81 | Potential Upside | 4.79 | Standard Deviation | 3.06 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Repligen historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Repligen Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Repligen, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Repligen back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | Brown Capital Management, Llc | 2024-12-31 | 954.9 K | Conestoga Capital Advisors, Llc | 2024-12-31 | 947.6 K | Geode Capital Management, Llc | 2024-12-31 | 944.1 K | Ameriprise Financial Inc | 2024-12-31 | 929.1 K | Point72 Asset Management, L.p. | 2024-12-31 | 918.6 K | Amvescap Plc. | 2024-12-31 | 905.1 K | Fmr Inc | 2024-12-31 | 754.4 K | Thrivent Financial For Lutherans | 2024-12-31 | 605.1 K | New York State Common Retirement Fund | 2024-12-31 | 581.4 K | T. Rowe Price Associates, Inc. | 2024-12-31 | 7.1 M | Blackrock Inc | 2024-12-31 | 6.9 M |
Repligen Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (29.3M) | (89.8M) | (57.2M) | 41.0M | 36.9M | 38.7M | |
| Change In Cash | 179.9M | (113.5M) | (80.4M) | 227.9M | (751.3M) | (713.8M) | |
| Free Cash Flow | 36.3M | 47.7M | 38.7M | 74.9M | 86.2M | 90.5M | |
| Depreciation | 27.1M | 38.4M | 51.0M | 68.1M | 78.3M | 82.2M | |
| Other Non Cash Items | 11.2M | 20.4M | (27.0M) | (15.0M) | 3.2M | 3.3M | |
| Capital Expenditures | 26.3M | 71.3M | 133.3M | 39.0M | 44.8M | 30.7M | |
| Net Income | 59.9M | 128.3M | 186.0M | 41.6M | (25.5M) | (26.8M) | |
| End Period Cash Flow | 717.3M | 603.8M | 523.5M | 751.3M | 864.0M | 907.2M | |
| Investments | (201.4M) | (221.2M) | (100M) | (74.7M) | (67.2M) | (70.6M) | |
| Change Receivables | (7.8M) | (20.9M) | (46.5M) | (3.6M) | (3.2M) | (3.4M) | |
| Change To Netincome | 18.5M | 13.3M | 34.9M | 25.9M | 29.7M | 31.2M |
Repligen Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Repligen or Life Sciences Tools & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Repligen's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Repligen stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.17 | |
β | Beta against Dow Jones | 1.08 | |
σ | Overall volatility | 3.11 | |
Ir | Information ratio | 0.05 |
Repligen Volatility Alert
Repligen shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Repligen's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Repligen's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Repligen Fundamentals Vs Peers
Comparing Repligen's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Repligen's direct or indirect competition across all of the common fundamentals between Repligen and the related equities. This way, we can detect undervalued stocks with similar characteristics as Repligen or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Repligen's fundamental indicators could also be used in its relative valuation, which is a method of valuing Repligen by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Repligen to competition |
| Fundamentals | Repligen | Peer Average |
| Return On Equity | -0.0128 | -0.31 |
| Return On Asset | 0.006 | -0.14 |
| Profit Margin | (0.04) % | (1.27) % |
| Operating Margin | 0.1 % | (5.51) % |
| Current Valuation | 8.39 B | 16.62 B |
| Shares Outstanding | 56.03 M | 571.82 M |
| Shares Owned By Insiders | 5.00 % | 10.09 % |
| Shares Owned By Institutions | 95.00 % | 39.21 % |
| Number Of Shares Shorted | 3.25 M | 4.71 M |
| Price To Earning | 154.58 X | 28.72 X |
| Price To Book | 4.29 X | 9.51 X |
| Price To Sales | 13.30 X | 11.42 X |
| Revenue | 634.44 M | 9.43 B |
| Gross Profit | 319.5 M | 27.38 B |
| EBITDA | 113.34 M | 3.9 B |
| Net Income | (25.51 M) | 570.98 M |
| Cash And Equivalents | 596.51 M | 2.7 B |
| Cash Per Share | 10.75 X | 5.01 X |
| Total Debt | 711.8 M | 5.32 B |
| Debt To Equity | 0.23 % | 48.70 % |
| Current Ratio | 2.30 X | 2.16 X |
| Book Value Per Share | 35.99 X | 1.93 K |
| Cash Flow From Operations | 113.92 M | 971.22 M |
| Short Ratio | 5.23 X | 4.00 X |
| Earnings Per Share | (0.46) X | 3.12 X |
| Price To Earnings To Growth | 2.59 X | 4.89 X |
| Target Price | 194.07 | |
| Beta | 0.95 | -0.15 |
| Market Capitalization | 8.44 B | 19.03 B |
| Total Asset | 2.83 B | 29.47 B |
| Retained Earnings | 438.85 M | 9.33 B |
| Working Capital | 952.88 M | 1.48 B |
| Current Asset | 103.25 M | 9.34 B |
Note: Disposition of 2380 shares by Anthony Hunt of Repligen at 164.74 subject to Rule 16b-3 [view details]
Repligen Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Repligen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Repligen Buy or Sell Advice
When is the right time to buy or sell Repligen? Buying financial instruments such as Repligen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Repligen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Disruptive Technologies Thematic Idea Now
Disruptive Technologies
New or established technology companies and funds across multiple sectors that are involved in development or marketing of products or services that experience disruptive trends and that are at the forefront of discussions on Wall Street. The Disruptive Technologies theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Disruptive Technologies Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Repligen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.83) | Earnings Share (0.46) | Revenue Per Share | Quarterly Revenue Growth 0.006 | Return On Equity |
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.